Browse drugs

…ng either cisplatin, docetaxel and 5-fluorouracil or cisplatin, docetaxel and capecitabine, followed by surgery and adjuvant radiotherapy…

… rather than to high-cost agents with marginal efficacy such as sotorasib or ramucirumab.Third, it is unacceptable to use inferior contro…

…mens alone (PF vs GP) and (I–L) depict the oral regimens alone (capecitabine vs S-1); within each panel set the endpoints are, respectively,…

…nical value of rezvilutamide combined with ADT, with or without docetaxel, as neoadjuvant treatment for newly diagnosed omHSPC.Trial regi…

…histology displayed a more pronounced immunological response to CAN-2409 treatment compared to patients with SQ histology. Improved immu…

…in response to both single-agent and combination treatment with carboplatin and docetaxel. Multiparameter flow cytometry demonstrated a het…

… and p=0.001, respectively). Out of 40 patients, 8 (40%) in the memantine group and 2 (10%) in the control group did not experience neuro…

…eceived abiraterone, 31% apalutamide, 26% enzalutamide, and 11% docetaxel. Median PFS and OS were 32 and 50 months, respectively, in the …

…ring may help identify patients who could benefit from extended osimertinib therapy, although further clinical validation is warranted.ctDN…

…d OS of 13.4 months,38 39 leading to full FDA approval in 2024. Adagrasib has also shown modest activity in PDAC (ORR 33%, PFS 5.4 months…

…on, and enhanced homing to solid tumors. Preparative regimen of Gemcitabine/Docetaxel has known activity across relapsed pediatric sarcomas…

…cancer immunotherapy clinical trials (OAK and POPLAR, comparing atezolizumab to docetaxel in non-small cell lung cancer) as well as a separa…